Sitravatinib in Metastatic Breast Cancer

NCT04123704 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Terminated by sponsor due to lack of interest

Conditions

Breast Cancer Stage IV
Triple Negative Breast Cancer
Breast Neoplasms
Breast Cancer Metastatic

Interventions

DRUG: Sitravatinib

Sponsor

Xiang Zhang

Collaborators

[object Object]